Calliditas Therapeutics AB
STO:CALTX

Watchlist Manager
Calliditas Therapeutics AB Logo
Calliditas Therapeutics AB
STO:CALTX
Watchlist
Price: 208 SEK 0.87% Market Closed
Market Cap: 11.2B SEK
Have any thoughts about
Calliditas Therapeutics AB?
Write Note

Calliditas Therapeutics AB
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Calliditas Therapeutics AB
Research & Development Peer Comparison

Comparables:
CAMX
S
SECARE
IRLAB A
MOB
I
FLERIE

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Calliditas Therapeutics AB
STO:CALTX
Research & Development
-kr557.9m
CAGR 3-Years
-34%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Research & Development
-kr731.3m
CAGR 3-Years
-66%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Research & Development
-kr2.4m
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Calliditas Therapeutics AB's Research & Development?
Research & Development
-557.9m SEK

Based on the financial report for Jun 30, 2024, Calliditas Therapeutics AB's Research & Development amounts to -557.9m SEK.

What is Calliditas Therapeutics AB's Research & Development growth rate?
Research & Development CAGR 5Y
-36%

Over the last year, the Research & Development growth was -33%. The average annual Research & Development growth rates for Calliditas Therapeutics AB have been -34% over the past three years , -36% over the past five years .

Back to Top